SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Runhaar Jos)
 

Sökning: WFRF:(Runhaar Jos) > (2017) > Subgroup analyses o...

  • Runhaar, JosErasmus University Medical Center (författare)

Subgroup analyses of the effectiveness of oral glucosamine for knee and hip osteoarthritis : A systematic review and individual patient data meta-Analysis from the OA trial bank

  • Artikel/kapitelEngelska2017

Förlag, utgivningsår, omfång ...

  • 2017-07-28
  • BMJ,2017
  • 8 s.

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:2e2abbc8-f41e-4165-9a0c-35dcd49be397
  • https://lup.lub.lu.se/record/2e2abbc8-f41e-4165-9a0c-35dcd49be397URI
  • https://doi.org/10.1136/annrheumdis-2017-211149DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:for swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • Objective To evaluate the effectiveness of oral glucosamine in subgroups of people with hip or knee osteoarthritis (OA) based on baseline pain severity, body mass index (BMI), sex, structural abnormalities and presence of inflammation using individual patient data. Methods After a systematic search of the literature and clinical trial registries, all randomised controlled trials (RCTs) evaluating the effect of any oral glucosamine substance in patients with clinically or radiographically defined hip or knee OA were contacted. As a minimum, pain, age, sex and BMI at baseline and pain as an outcome measure needed to be assessed. Results Of 21 eligible studies, six (n=1663) shared their trial data with the OA Trial Bank. Five trials (all independent of industry, n=1625) compared glucosamine with placebo, representing 55% of the total number of participants in all published placebo-controlled RCTs. Glucosamine was no better than placebo for pain or function at short (3 months) and long-Term (24 months) follow-up. Glucosamine was also no better than placebo among the predefined subgroups. Stratification for knee OA and type of glucosamine did not alter these results. Conclusions Although proposed and debated for several years, open trial data are not widely made available for studies of glucosamine for OA, especially those sponsored by industry. Currently, there is no good evidence to support the use of glucosamine for hip or knee OA and an absence of evidence to support specific consideration of glucosamine for any clinically relevant OA subgroup according to baseline pain severity, BMI, sex, structural abnormalities or presence of inflammation.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Rozendaal, Rianne M.Erasmus University Medical Center (författare)
  • van Middelkoop, MarienkeErasmus University Medical Center (författare)
  • Bijlsma, Hans J.W.University Medical Center Utrecht (författare)
  • Doherty, MichaelUniversity of Nottingham (författare)
  • Dziedzic, Krysia S.Keele University (författare)
  • Lohmander, L. StefanLund University,Lunds universitet,Ortopedi, Lund,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Orthopaedics (Lund),Section III,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)ort-slo (författare)
  • McAlindon, Timothy ETufts Medical Center (författare)
  • Zhang, WeiyaUniversity of Nottingham(Swepub:lu)chem-wzn (författare)
  • Bierma-Zeinstra, Sita MErasmus University Medical Center (författare)
  • Erasmus University Medical CenterUniversity Medical Center Utrecht (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Annals of the Rheumatic Diseases: BMJ76:11, s. 1862-18690003-49671468-2060

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy